Lung Inflammation: Clinical Trials

4 trials for Lung Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 3, Recruiting 1

Follow Lung Inflammation: new trials by email Literature Review of Lung Inflammation trials Research Report on Lung Inflammation

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET Imaging CCR2 in Lung Inflammation
Cu-DOTA-ECL1i - Lung Inflammation
Early Phase 1RecruitingWashington University School of Medicine1102018-02-272026-05-01
Assessing NOS Uptake With PET Imaging in Lung Inflammation
Endotoxin (E. coli O:113, Reference Endotoxin), [18F](+/-)NOS - Lung Inflammation
Early Phase 1CompletedWashington University School of Medicine32014-05-012018-07-23
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
Zileuton, Pioglitazone placebo, Zileuton placebo - Lung Inflammation
Early Phase 1CompletedWashington University School of Medicine392011-07-012014-04-23
Quantifying Airway Inflammation With Radiologic Tests
placebo pill and placebo IV, Lovastatin pill and placebo IV, placebo pill and recombinant human activated protein C IV - Lung Inflammation
Early Phase 1CompletedWashington University School of Medicine222007-03-012014-05-26

Narrower conditions

Pneumonia (4)

Broader conditions

Infections (4)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)

Interventions

Endotoxins (2)  ·  Lipopolysaccharides (2)  ·  Fluorine-18 (1)  ·  Lovastatin (1)  ·  Pioglitazone (1)  ·  drotrecogin alfa activated (1)  ·  zileuton (1)

Sponsors

Washington University School of Medicine (4)

Countries

United States (4)

Top investigators

Delphine L Chen, MD (2)  ·  Delphine Chen, MD (1)  ·  Steven Brody, MD (1)

Results publications

PMID 19574441, PMID 29414995, PMID 32673071

NIH funding

R01HL151685 (1)